BAT and MAT for diagnosis of peanut allergy: A systematic review and meta‐analysis
Pediatric Allergy and Immunology · 2024
DOI: 10.1111/pai.14140 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Alexandre Piletta-Zanin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva (HUG), Geneva, Switzerland. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Sensitivity and Specificity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Basophil activation test (BAT) or the mast cell activation test (MAT) are two in vitro tests that are currently being studied in food allergy as diagnostic tools as an alternative to oral food challenges (OFCs). We conducted a meta‐analysis on BAT and MAT, assessing their specificity and sensitivity in diagnosing peanut allergy. Six databases were searched for studies on patients suspected of having peanut allergy. Studies using BAT or MAT to peanut extract and/or component as diagnostic tools with results given in percentage of CD63 activation were included in this meta‐analysis. Study quality was evaluated with the QUADAS‐2 tool. On the 11 studies identified, eight focused exclusively on children, while three included a mixed population of adults and children. Only one study provided data on MAT, precluding us from conducting a statistical analysis. The diagnostic accuracy of BAT was higher when stimulated with peanut extract rather than Ara h 2 with a pooled specificity of 96% (95% CI: 0.89–0.98) and sensitivity of 0.86 (95% CI: 0.74–0.93). The sensitivity and specificity of BATs in discriminating between allergic and sensitized patients were studied as well, with pooled analysis revealing a sensitivity of 0.86 (95% CI: 0.74; 0.93) and a specificity of 0.97 (95% CI: 0.94, 0.98). BATs, when stimulated with peanut extracts, exhibit a satisfactory sensitivity and specificity for the diagnosis of peanut allergy and can help to discriminate between allergic individuals and those only sensitized to peanuts. More investigations on the potential for MATs diagnostic methods are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva (HUG), Geneva, Switzerland.
- Africa Unit for Transdisciplinary Health Research (AUTHeR), North-West University, Potchefstroom, South Africa.
- Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
- Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.
ORCID-Profile: Alexandre Piletta-Zanin, Alexandra F Santos
Zitieren
APA
Piletta-Zanin, A., Ricci, C., Santos, A. F., & Eigenmann, P. A. (2024). BAT and MAT for diagnosis of peanut allergy: A systematic review and meta‐analysis. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14140
Vancouver
Piletta-Zanin A, Ricci C, Santos AF, Eigenmann PA. BAT and MAT for diagnosis of peanut allergy: A systematic review and meta‐analysis. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14140
BibTeX
@article{PilettaZanin2024,
author = {Piletta-Zanin, Alexandre and Ricci, Christian and Santos, Alexandra F and Eigenmann, Philippe A},
title = {BAT and MAT for diagnosis of peanut allergy: A systematic review and meta‐analysis},
journal = {Pediatric Allergy and Immunology},
year = {2024},
doi = {10.1111/pai.14140}
}
EUVIMED